Enterprise Value
-100M
Cash
197.9M
Avg Qtr Burn
-14.21M
Short % of Float
2.87%
Insider Ownership
2.61%
Institutional Own.
92.56%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Rezatapopt/ PC14586 (p53 reactivator) +/- KEYTRUDA Details Solid tumor/s, Cancer | Phase 2 Data readout |